| Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey A Versporten, P Zarb, I Caniaux, MF Gros, N Drapier, M Miller, V Jarlier, ... The Lancet Global Health 6 (6), e619-e629, 2018 | 617 | 2018 |
| European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli … M Paul, E Carrara, P Retamar, T Tängdén, R Bitterman, RA Bonomo, ... Clinical Microbiology and Infection 28 (4), 521-547, 2022 | 504 | 2022 |
| Escherichia coli: an old friend with new tidings J Vila, E Sáez-López, JR Johnson, U Römling, U Dobrindt, R Cantón, ... FEMS microbiology reviews 40 (4), 437-463, 2016 | 419 | 2016 |
| Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachon, ... Clinical Microbiology and Infection 26 (11), 1525-1536, 2020 | 368 | 2020 |
| β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase–Producing Escherichia coli: A Post Hoc … J Rodriguez-Bano, MD Navarro, P Retamar, E Picon, A Pascual, ... Clinical Infectious Diseases 54 (2), 167-174, 2012 | 360 | 2012 |
| Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis P Retamar, MM Portillo, MD López-Prieto, F Rodríguez-López, ... Antimicrobial agents and chemotherapy 56 (1), 472-478, 2012 | 244 | 2012 |
| Extended-Spectrum Beta-Lactamases–Red Española de Investigación en Patología Infecciosa/Grupo de Estudio de Infección Hospitalaria Group. β-Lactam/β-lactam inhibitor … J Rodríguez-Baño, MD Navarro, P Retamar, E Picón, Á Pascual Clin Infect Dis 54 (2), 167-174, 2012 | 184 | 2012 |
| Epidemiology and clinical features of community‐acquired, healthcare‐associated and nosocomial bloodstream infections in tertiary‐care and community hospitals J Rodríguez‐Baño, MD López‐Prieto, MM Portillo, P Retamar, C Natera, ... Clinical Microbiology and Infection 16 (9), 1408-1413, 2010 | 170 | 2010 |
| Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli P Retamar, L López-Cerero, MA Muniain, Á Pascual, J Rodríguez-Baño, ... Antimicrobial agents and chemotherapy 57 (7), 3402-3404, 2013 | 110 | 2013 |
| A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients M Bartoletti, M Giannella, R Lewis, P Caraceni, S Tedeschi, M Paul, ... Clinical Microbiology and Infection 24 (5), 546. e1-546. e8, 2018 | 100 | 2018 |
| Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): Results from a worldwide point prevalence … I Pauwels, A Versporten, N Drapier, E Vlieghe, H Goossens Journal of Antimicrobial Chemotherapy 76 (6), 1614-1624, 2021 | 93 | 2021 |
| Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial J Molina, E Montero-Mateos, J Praena-Segovia, E León-Jiménez, ... Clinical Microbiology and Infection 28 (4), 550-557, 2022 | 91 | 2022 |
| Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study B Gutiérrez-Gutiérrez, MD Del Toro, AM Borobia, A Carcas, I Jarrín, ... The Lancet infectious diseases 21 (6), 783-792, 2021 | 80 | 2021 |
| Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and … J Rodríguez-Baño, JM Cisneros, N Cobos-Trigueros, G Fresco, ... Enfermedades infecciosas y microbiologia clinica 33 (5), 337. e1-337. e21, 2015 | 79 | 2015 |
| A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance JM López-Lozano, T Lawes, C Nebot, A Beyaert, X Bertrand, D Hocquet, ... Nature Microbiology 4 (7), 1160-1172, 2019 | 77 | 2019 |
| Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum β-lactamase-producing Escherichia coli in the … G Peñalva, R Fernández-Urrusuno, JM Turmo, R Hernández-Soto, ... The Lancet Infectious Diseases 20 (2), 199-207, 2020 | 71 | 2020 |
| Current management of bloodstream infections J Rodriguez-Bano, M De Cueto, P Retamar, J Galvez-Acebal Expert review of anti-infective therapy 8 (7), 815-829, 2010 | 70 | 2010 |
| Autoantibodies against type I IFNs in patients with critical influenza pneumonia Q Zhang, A Pizzorno, L Miorin, P Bastard, A Gervais, T Le Voyer, L Bizien, ... Journal of Experimental Medicine 219 (11), e20220514, 2022 | 63 | 2022 |
| Effectiveness of fosfomycin for the treatment of multidrug-resistant Escherichia coli bacteremic urinary tract infections: a randomized clinical trial J Sojo-Dorado, I López-Hernández, C Rosso-Fernandez, IM Morales, ... JAMA network open 5 (1), e2137277-e2137277, 2022 | 58 | 2022 |
| Management of bloodstream infections by infection specialists: an international ESCMID cross-sectional survey K Diallo, N Thilly, A Luc, G Beraud, Ö Ergonul, M Giannella, D Kofteridis, ... International journal of antimicrobial agents 51 (5), 794-798, 2018 | 58 | 2018 |
Jesus Rodriguez-BañoHosp. Univ. Virgen Macarena / Universidad de Sevilla / Instituto de Biomedicina de Sevilla (IBiS)在 us.es 的电子邮件经过验证
